There is no algorithm which identifies the BRCA1/2 negativity in the literature; in addition, there is no available algorithm that describes the BRCA1/2 negativity by only evaluating the clinical and demographic data of patients without performing the BRCA1/2 gene test in high-risk breast cancer patients with a family history. The gene discussed is BRCA1; the disease is breast carcinoma.